Absence of mycoplasma contamination in the anthrax vaccine

Emerging Infectious Diseases

Volumn 8, Issue 1, 2002, Pages 94-96

  Hart, Mary Kate ^a   Del Giudice, Richard A ^b   Korch Jr , George W ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE;

ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; GRAM NEGATIVE INFECTION; HUMAN; MILITARY MEDICINE; MYCOPLASMA; PERSIAN GULF SYNDROME; SOLDIER;

EID: 0036151416     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0801.010091     Document Type: Article

References (9)

1. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. The vaccine adverse event reporting system (VAERS)
3. Anthrax vaccine: Controversy over safety and efficacy
4. A culture medium formulation for primary isolation and maintenance of mollicutes
5. Isolation ofmycoplasma from cell cultures by axenic techniques
6. M-CMRL, a new axenic medium to replace indicator cell cultures for the isolation of all strains of M hyorhinis
7. Genetic and serologic relatedness between Mycoplasma fermentans strains and a mycoplasma recently identified in tissues of AIDS and non-AIDS patients
8. Test of Iraqi anthrax vaccine and other vaccines
9. No serological evidence of an association found between Gulf War service and Mycoplasma fermentans infection